Axogen, Inc. to Report Third Quarter 2026 Financial Results on October 28, 2026
Key Highlights
- ➤Axogen will release third-quarter 2026 financial results on October 28, 2026
- ➤Management will host an investment-community conference call and webcast at 8:00 a.m. ET
- ➤Axogen’s portfolio includes Avance nerve grafts and multiple Axoguard nerve-repair products
ALACHUA, Fla. and TAMPA, Fla., Oct. 14, 2026 (GLOBE NEWSWIRE) -- Axogen, Inc. (Nasdaq: AXGN), a global leader in developing and marketing innovative surgical solutions for the restoration of peripheral nerve function, today announced that it will release financial results for the third quarter of 2026 on Wednesday, October 28, 2026. Axogen management will host an investment-community conference call and webcast at 8:00 a.m. ET following the release.
Investors interested in participating in the conference call by phone may dial toll-free at (877) 407-0993 or use the direct dial-in number at (201) 689-8795. A live webcast, an archived replay, and presentation slides from the event are available on the Investors page of the company's website at www.axogeninc.com.
Get started
Create a free account to read the full story.